Reductions in Methicillin-resistant Staphylococcus aureus, Clostridium difficile Infection and Intensive Care Unit-Acquired Bloodstream Infection Across the United Kingdom Following Implementation of a National Infection Control Campaign
Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile infections declined across the UK National Health Service in the decade that followed implementation of an infection control campaign. The national impact on intensive care unit (ICU)-acquired infections has not been documented. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 23, 2020 Category: Consumer Health News Source Type: news

Dartmouth-led team engineers new treatment for drug-resistant bacterial infections
(Thayer School of Engineering at Dartmouth) A new antibacterial agent that has been engineered by researchers at Dartmouth to essentially hide from the human immune system may treat life-threatening MRSA infections. A new paper, published today in Science Advances, provides details on the agent, which is the first lysin-based treatment with the potential to be used multiple times on a single patient, making it ideal to treat particularly persistent drug-resistant and drug-sensitive infections. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 2, 2020 Category: International Medicine & Public Health Source Type: news

Saved by the Saxons! The disgusting 10th-century potion that could beat superbugs
Made from cow ’s bile, garlic and onions, Bald’s eyesalve was meant to cure styes, but scientists believe it could deal with antibiotic-resistant bacterial infectionsName:Bald ’s eyesalve.Age: 1,000 years old.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 29, 2020 Category: Science Tags: Medical research MRSA and superbugs Science Alternative medicine Life and style Source Type: news

Beautyberry leaf extract restores drug's power to fight 'superbug'
(Emory Health Sciences) Laboratory experiments showed that the plant compound works in combination with oxacillin to knock down the resistance to the drug of methicillin-resistant Staphylococcus aureus, or MRSA. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 16, 2020 Category: Infectious Diseases Source Type: news

MolecuLight Launches i:X(R) Sterile Surgical Sleeve for Imaging of Bacteria in Wounds in a Surgical Setting
New Disposable Sleeve allows MolecuLight i:X to Be Used in Operating Rooms (for skin grafts and skin substitutes), in Covid-19 Wards and in MRSA Isolation Wards TORONTO, July 9, 2020 -- (Healthcare Sales & Marketing Network) - MolecuLight Inc., the lea... Devices, Surgery, Wound Care, Product Launch MolecuLight, MolecuLight i:X, fluorescence imaging, i:X Sterile Surgical Sleeve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 9, 2020 Category: Pharmaceuticals Source Type: news

Epidemiology of burn-related infections in the largest burn unit in Saudi Arabia - Mater ME, Yamani AE, Aljuffri AA, Binladen SA.
OBJECTIVES: To first describe the epidemiological data of burns, including burn types and burn-related infections, in adult and pediatric patients. Second, to determine the effect of Methicillin-Resistant Staphylococcus aureus (MRSA) on length of hospital ... (Source: SafetyLit)
Source: SafetyLit - July 4, 2020 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

New strategy emerges for vaccine against methicillin-resistant staphylococcal aureus
(NYU Langone Health / NYU School of Medicine) Experiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 30, 2020 Category: Infectious Diseases Source Type: news

MRSA Fast Facts
Read CNN's Fast Facts about MRSA and learn more about the bacteria that is resistant to all beta-lactam antibiotics. (Source: CNN.com - Health)
Source: CNN.com - Health - June 20, 2020 Category: Consumer Health News Source Type: news

What Causes Pyogenic Granulomas?
Discussion Pyogenic granuloma (PG) is a benign, vascular lesion of the skin. PGs are red, small, often pedunculated nodules that can rapidly increase in size (up to 1-2 cm). They also can often ulcerate and bleed. They frequently occur on the head and neck, with back and chest being the next most common locations but can occur in other locations. They usually are solitary and do not regress. They are seen in children (mean age 6.7 years), young adults and pregnant women (5%). Treatment is electrocautery or excision. Learning Point PG’s cause is not fully understood. A gene has recently been identified with PG sugge...
Source: PediatricEducation.org - June 15, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Prevalence ofAntibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use
Conclusions and Relevance: In this study, most patients with community-onset sepsis did not have resistant pathogens, yet broad-spectrum antibiotics were frequently administered. Both inadequate and unnecessarily broad empiric antibiotics were associated with higher mortality. These findings underscore the need for better tests to rapidly identify patients with resistant pathogens and for more judicious use of broad-spectrum antibiotics for empiric sepsis treatment. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 6, 2020 Category: Consumer Health News Source Type: news

Bacterial and fungal etiology of sepsis in children in the United States: Reconsidering empiric therapy
Conclusion(s): In this nationally representative administrative database, the most common identified pathogen was S. aureus in previously healthy and chronically ill children. In addition, a high proportion of children with sepsis and select chronic diseases had infections with methicillin-resistant S. aureus, fungal infections, Pseudomonas infections, and C. difficile. Clinicians caring for pediatric patients should consider coverage of these organisms when administering empiric antimicrobials for sepsis. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 6, 2020 Category: Consumer Health News Source Type: news

‘No One Mentions the People Who Clean It Up’: What It’s Like to Clean Professionally During the COVID-19 Outbreak
When Vanessa is asked to clean up after patients who have the seasonal flu or measles or MRSA in the Pennsylvania hospital where she works in environmental services, she knows what to do. She knows how to disinfect surfaces, what needs to be thrown away and what she should wear to protect herself. But when she’s asked to clean rooms occupied by COVID-19 patients, she’s flying blind. “It’s kind of terrifying,” says Vanessa, who TIME is identifying by first name only for professional protection. Her supervisors told her to clean the rooms just as she would for a flu patient, but she says she&rsq...
Source: TIME: Health - March 31, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

Marshall University scientists receive NIH grant for new anti-MRSA antibiotic study
(Marshall University Joan C. Edwards School of Medicine) Three Marshall University scientists received a three-year grant from the National Institutes of Health (NIH) to study the use of disulfiram in the treatment of antibiotic-resistant Staphylococcus aureus infections. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 27, 2020 Category: Infectious Diseases Source Type: news

McMaster researchers uncover hidden antibiotic potential of cannabis
(McMaster University) The research team found that CBG had antibacterial activity against drug-resistant MRSA. It prevented the ability of that bacteria to form biofilms, which are communities of microorganisms that attach to each other and to surfaces; and it destroyed preformed biofilms and cells resistant to antibiotics. CBG achieved this by targeting the cell membrane of the bacteria. These findings in the laboratory were supported when mice with an MRSA infection were given CBG. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 26, 2020 Category: Infectious Diseases Source Type: news

Cannabis compound acts as an antibiotic  
(American Chemical Society) Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity's most critical challenges. However, scientists haven't discovered a new class of antibiotics in more than 30 years. Now, researchers reporting in ACS Infectious Diseases have uncovered the hidden antibiotic potential of a non-psychoactive cannabis compound called cannabigerol (CBG), which helped control methicillin-resistant Staphylococcus aureus (MRSA) infections in mice. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 26, 2020 Category: International Medicine & Public Health Source Type: news

Increased Mortality Seen With Empirical Anti-MRSA Treatment for Pneumonia Increased Mortality Seen With Empirical Anti-MRSA Treatment for Pneumonia
Empirical anti-MRSA treatment is associated with an increased risk of 30-day mortality in patients hospitalized for pneumonia, compared with standard antibiotic therapy, according to a retrospective study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 22, 2020 Category: Pathology Tags: Pulmonary Medicine News Source Type: news

Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia
US-based cohort study of 88,605 hospitalisations for pneumonia did not find a mortality benefit for treatment with empirical anti –methicillin-resistant S aureus (MRSA) therapy vs standard antibiotics for any group of patients examined, even those with risk factors for MRSA. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 20, 2020 Category: Consumer Health News Source Type: news

Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial
RCT (n=352) found no significant difference in the primary composite end point of mortality, persistent bacteremia, relapse, or treatment failure for addition of an antistaphylococcal β-lactam to standard antibiotic therapy (vancomycin or daptomycin) vs standard therapy alone. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 13, 2020 Category: Consumer Health News Source Type: news

Drug Combo No Better in MRSA Blood Infections, Ups Risk Drug Combo No Better in MRSA Blood Infections, Ups Risk
Adding a beta-lactam to standard therapy for MRSA bacteremia does not improve outcomes and appears to up the risk for kidney injury, data from a randomized controlled trial showed.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - February 11, 2020 Category: Internal Medicine Tags: Infectious Diseases News Source Type: news

Trial shows using two drugs not better than one when treating MRSA blood infections
(University of Melbourne) Researchers attempting to improve the treatment for methicillin-resistant Staphylococcus aureus (MRSA) blood infections have discovered the combination of two antibiotics was no better than one, and led to more adverse effects. In what is the biggest trial of MRSA bloodstream infections to date, (352 participants from Australia, Singapore, New Zealand and Israel), the CAMERA2 clinical trial, researchers were surprised to see the drug combination wasn't as effective as anticipated. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 11, 2020 Category: Infectious Diseases Source Type: news

The Coronavirus Outbreak Should Bring Out the Best in Humanity
Pandemics are perversely democratic. They’re nasty, lethal and sneaky, but they don’t discriminate. No matter your age, ethnicity, religion, gender, or nation, you’re a part of the pathogenic constituency. That shared vulnerability, and the resulting human collectivism—a universal response to a universal threat—is newly and vividly evident in the face of the now-global outbreak of the novel coronavirus known as 2019-nCoV. As of writing, there have been over 30,000 diagnosed cases and over 630 related deaths. A virus that emerged in a single city, Wuhan, China—indeed, in a single crowded ...
Source: TIME: Health - February 8, 2020 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized 2019-nCoV Infectious Disease Source Type: news

FDA Tells Purell Maker to Stop Making False Claims
The agency warned Gojo Industries that unsubstantiated claims that Purell can help prevent illnesses such as the flu, Ebola virus, norovirus and the MRSA superbug violate federal laws, The New York Times reported Tuesday. (Source: WebMD Health)
Source: WebMD Health - January 29, 2020 Category: Consumer Health News Source Type: news

F.D.A. Warns Purell to Stop Claiming It Can Prevent Ebola or Flu
The Food and Drug Administration told the maker of Purell hand sanitizers to discontinue marketing campaigns that the agency complained also included claims for avoiding illness from other viruses. (Source: NYT Health)
Source: NYT Health - January 29, 2020 Category: Consumer Health News Authors: Sheila Kaplan Tags: Purell Drugs (Pharmaceuticals) Cleansers, Detergents and Soaps Methicillin-Resistant Staphylococcus Aureus Influenza Norovirus Ebola Virus Gojo Industries Inc Food and Drug Administration Hygiene and Cleanliness your-feed-healthcare Source Type: news

FDA Warns Purell To Stop Making Unproven Claims About Hand Sanitizers
(CNN) — The US Food and Drug Administration is giving the maker of Purell products a stern warning: Stop making unproven claims that over-the-counter hand sanitizers help eliminate Ebola, MRSA or the flu. In a “warning letter” to Purell’s parent, Gojo Industries, the agency called out the company for making numerous marketing claims that potentially position its sanitizing products as a pharmaceutical drug rather than an over-the-counter topical antiseptic. The letter from the agency’s director of compliance cited numerous examples of what the FDA says are unproven claims for Purell products m...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 27, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston CNN Hand Sanitizer Source Type: news

Nasal and Skin Decolonization Safely Replaces Contact Precautions for MRSA-Colonized Patients Nasal and Skin Decolonization Safely Replaces Contact Precautions for MRSA-Colonized Patients
Nasal and skin decolonization safely and less expensively replaced contact precautions for patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) at one U.S. hospital network, according to a new report.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 27, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

UK still free of coronavirus cases
Patients with symptoms advised to call GP rather than attend practice Related items fromOnMedica Warn patients that natural malaria immunity fades Single-dose malaria drug eliminates parasite from liver Should we have compulsory measles vaccination at school entry? Parents still following folklore methods for cold prevention Double check patients with ‘penicillin’ allergy to avoid MRSA risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 27, 2020 Category: UK Health Source Type: news

Lack of antibiotics in low income countries 'worsening  superbugs threat'
Only three new treatments available in 10 or more poorer countries, report findsMany antibiotics are unavailable in poorer countries despite higher infection rates, exacerbating the threat of drug-resistant superbugs, according to a report to bepresented to world leaders and the bosses of top pharmaceutical companies in Davos.The report, released by the Access to Medicine Foundation, an Amsterdam-based non-profit group, also shows that the number of new treatments being developed for common infectious diseases such as pneumonia, tuberculosis and gonorrhoea has fallen.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 21, 2020 Category: Science Authors: Julia Kollewe Tags: Antibiotics Business Davos 2020 Drugs MRSA and superbugs Health Source Type: news

Cannabis compound could be weapon in fight against superbugs
Mice cured of MRSA, raising hopes of treating antibiotic-resistant bacteriaA compound made by cannabis plants has been found to wipe out drug-resistant bacteria, raising hopes of a new weapon in the fight against superbugs.Scientists screened five cannabis compounds for their antibiotic properties and found that one, cannabigerol (CBG), was particularly potent at killing methicillin-resistant Staphylococcus aureus (MRSA), one of the most common hospital superbugs.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - January 19, 2020 Category: Science Authors: Ian Sample Science editor Tags: Drug resistance Antibiotics Medical research Cannabis Science UK news Source Type: news

Wockhardt gets DGCI approval for 2 new antibiotics
"DCGI (Drug Controller General of India) has approved Wockhardt's two new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial skin and skin structure infections including diabetic foot infections and concurrent bacteraemia...," the drug firm said. The new drug will target superbug like Methicillin resistant Staphylococcus aureus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 16, 2020 Category: Pharmaceuticals Source Type: news

NHS declares victory on MRSA and takes fight to E coli
Trusts and clinical commissioning groups face new annual targets designed to combat rising levels of four bloodstream infections, but sanctions relating to MRSA and C difficile could be scrapped. (Source: HSJ)
Source: HSJ - January 10, 2020 Category: UK Health Source Type: news

New Strategies to Prevent MRSA Infections in Your Hospital New Strategies to Prevent MRSA Infections in Your Hospital
A community hospital's rate of MRSA bloodstream infections is much higher than the national rate. Would you know what to do to reverse this trend?CDC Expert Commentary (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - December 23, 2019 Category: Infectious Diseases Tags: Infectious Diseases Case Challenge Source Type: news

It takes “2 weeks to build up immunity” to the flu after the vaccine is administered, claims the industry that has paid out over $2 billion for flu shot injuries
(Natural News) Nurses and doctors across America will beg and plead with you to get your flu shot “early” so you can build up immunity to the known mass serial killer called influenza. Yet, most people who die from the flu didn’t really. They died from pneumonia, MRSA superbugs and a crippled immune system caused... (Source: NaturalNews.com)
Source: NaturalNews.com - December 22, 2019 Category: Consumer Health News Source Type: news

The new polymer can kill drug-resistant bacteria
Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, and Nanyang Technological University (NTU) have designed an antimicrobial polymer that can kill bacteria resistant to commonly used antibiotics, including the superbug Methicillin-resistant Staphylococcus aureus (MRSA). (Source: World Pharma News)
Source: World Pharma News - December 12, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

FDA Clears Faster Diagnostic Test for MRSA
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 6, 2019 Category: General Medicine Source Type: news

FDA Clears Faster Diagnostic Test for MRSA FDA Clears Faster Diagnostic Test for MRSA
The cobas vivoDx MRSA test uses a new bacteriophage technology based on bioluminescence to detect MRSA from nasal swab samples in 5 hours or less compared with 24 to 48 hours for conventional cultures.FDA Approvals (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - December 6, 2019 Category: Emergency Medicine Tags: Infectious Diseases News Alert Source Type: news

Survey finds high level of self-prescribing among doctors
Young doctors also prescribing to friends and family Related items fromOnMedica GPs need more time to treat complex needs GPs defend practice on prescribing statins Double check patients with ‘penicillin’ allergy to avoid MRSA risk Clinicians need better options if we are to stop over-medication MHRA tightens licence restrictions on valproate for women (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 4, 2019 Category: UK Health Source Type: news

MRSA Spreads Easily in Households MRSA Spreads Easily in Households
Methicillin-resistant Staphylococcus aureus (MRSA) can spread easily from people to household pets, according to a new study that underscores the importance of frequent handwashing.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - November 28, 2019 Category: Pathology Tags: Infectious Diseases News Source Type: news

Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: a prospective cohort study
Review of 150 children with community-associated MRSA (caMRSA) skin and soft tissue infections found that sharing bedrooms, sharing bath towels and living in homes with a higher environmental contamination burden increased the likelihood of spread of caMRSA. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 28, 2019 Category: Consumer Health News Source Type: news

Household Environment Plays Role in MRSA Acquisition
WEDNESDAY, Nov. 27, 2019 -- The household environment plays a key role in the acquisition of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infection, according to a study published online Nov. 26 in The Lancet Infectious... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 27, 2019 Category: Pharmaceuticals Source Type: news

Drug-resistant staph spreads easily in households
(Reuters Health) - The superbug MRSA (methicillin-resistant Staphylococcus aureus) can spread easily from people to household pets, according to a new study that underscores the importance of frequent handwashing. (Source: Reuters: Health)
Source: Reuters: Health - November 27, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

This New Compound May Be Able To Battle A Common Hospital Superbug
Researchers in Canada have identified a new compound which makes superbug MRSA susceptible to treatment with common antibiotics again. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 26, 2019 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Potent antimicrobial found that shows promise in fighting staph infections
(McMaster University) After screening thousands of small molecules, the research team discovered a potent new antimicrobial they are calling MAC-545496 that is active against MRSA. Unlike conventional antibiotics, this new antimicrobial neither kills the staph infection nor halts its growth on its own, so the potential for antimicrobial resistance may be considerably lessened. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 25, 2019 Category: Infectious Diseases Source Type: news

Drug-resistant staph can spread easily in household environments
(Washington University in St. Louis) Once rare, the superbug methicillin-resistant Staphylococcus aureus (MRSA) infects hundreds of thousands of people in the US each year and kills about 20,000. New research led by Washington University School of Medicine in St. Louis sheds light on how MRSA is introduced into households and, once there, how it can spread among family members, including the furry ones. Understanding MRSA's transmission dynamics is critical to devising effective preventive tactics. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 21, 2019 Category: Infectious Diseases Source Type: news

A Tiny Bug Ended My NFL Career —and Almost My Life
During my nine years in the NFL, I ruptured tendons in my fingers, suffered multiple concussions, and broke several bones. I tore my ACL, MCL, and PCL, and completely blew out my left knee. That last injury should have ended my career. But it didn’t. I put myself back together and played through the pain. What finally took me down? A tiny bug I had never heard of and couldn’t see. A drug-resistant staph infection called methicillin-resistant Staphylococcus aureus cost me my NFL career—and almost my life. MRSA is one of many deadly, antibiotic-resistant infections. Together, these “superbugs” k...
Source: TIME: Health - November 19, 2019 Category: Consumer Health News Authors: Brandon Noble Tags: Uncategorized health Source Type: news

Nearly half of older adults think they ’ll get dementia
But few discuss prevention with their physician Related items fromOnMedica Experts urge radical action on mental health crises Double check patients with ‘penicillin’ allergy to avoid MRSA risk Social prescribing workers to ease GP pressure Scotland launches its ‘Detect Cancer Early’ campaign Midwives demand ‘equivalence’ in prison perinatal care (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 18, 2019 Category: UK Health Source Type: news

Scientists discover how potent bacterial toxin kills MRSA bacteria
(University of Sheffield) Scientists from the University of Sheffield have discovered how a potent bacterial toxin is able to target and kill MRSA, paving the way for potential new treatments for superbugs. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 4, 2019 Category: Infectious Diseases Source Type: news

Test can tell whether bacteria is resistant to antibiotics in less than 45 minutes
The new method, developed by experts at the University of Strathclyde in Scotland, was tested on staphylococcus aureus and MRSA. (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2019 Category: Consumer Health News Source Type: news

Genetic mutation may help people fight off deadly MRSA infections
Scientists from Duke University analysed 68 people, half of which had a persistent MRSA infection, while the remaining 34 participants managed to clear the bacteria from their bloodstream. (Source: the Mail online | Health)
Source: the Mail online | Health - September 17, 2019 Category: Consumer Health News Source Type: news

Infection prevention control and organisational patient safety culture within the context of isolation: study protocol
Healthcare associated infection (HCAI) is a major cause of morbidity and mortality. In recent years, there have been high profile successes in infection prevention control (IPC), such as the dramatic reductions in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (which is viewed as one proxy indicator of overall harm) and Clostridium difficile in the UK. Nevertheless, HCAI remains a costly burden to health services, a source of concern to patients and the public and at present, is receiving priority from policy makers as it contributes to the global threat of antimicrobial resistance. (Source: Curr...
Source: Current Awareness Service for Health (CASH) - September 12, 2019 Category: Consumer Health News Source Type: news

Medical News Today: Antibiotic resistance can spread in the absence of drugs
Using mice, scientists have recently identified a mechanism independent of antibiotic use that can spread drug resistance among intestinal bacteria. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 9, 2019 Category: Consumer Health News Tags: MRSA / Drug Resistance Source Type: news